Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

Kidney International

Volumn 76, Issue 10, 2009, Pages 1116-

  Morelle, Johann ^a   Labriola, Laura ^a   Jadoul, Michel ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ERYTHROPOIETIN; FLUINDOSTATIN; HEPCIDIN;

CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HORMONE BLOOD LEVEL; HUMAN; KIDNEY DISEASE; LETTER; NONHUMAN; PRIORITY JOURNAL;

EID: 70350655969     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.334     Document Type: Letter

References (4)

1. Ashby DR, Gale DP, Busbridge M et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009; 75: 976-981.
2. Tomosugi N, Kawabata H, Wakatabe R et al. Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System. Blood 2006; 108: 1381-1387.
3. Clark WR, Ronco C. Determinants of haemodialyser performance and the potential effect on clinical outcome. Nephrol Dial Transplant 2001; 16S5: 56-60.
4. Arabul M, Gullulu M, Yilmaz Y et al. Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease. Clin Biochem 2008; 41: 1055-1058.